Skip to main navigation Skip to search Skip to main content

The Economic Impact of Changing Levothyroxine Formulations in Difficult-to-Treat Hypothyroid Patients: An Evidence-Based Model

Research output: Contribution to journalArticlepeer-review

Original languageAmerican English
JournalPharmacoeconomics
Volume35
StatePublished - Jan 1 2017

Disciplines

  • Pharmacy and Pharmaceutical Sciences

Cite this